Effect of Physiotherapy Methods on Functional and Respiratory Outcomes in ICU Patients With Respiratory Failure
NCT ID: NCT06912308
Last Updated: 2025-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
150 participants
INTERVENTIONAL
2023-09-30
2027-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is expected that the results, conclusions, and practical clinical recommendations derived from this study will be beneficial not only for rehabilitation specialists and intensivists in Lithuania but also for medical professionals working with respiratory diseases, including COVID-19 patients, at various stages of their treatment and consultation.
Implementing an appropriate physiotherapy procedure protocol is anticipated to bring economic benefits, as early physiotherapy is safe and can reduce the incidence of delirium, decrease the duration of patient sedation, shorten the number of days on mechanical ventilation, and minimize hospital stay duration. Additionally, it aims to restore or improve patients' functional and independence levels, help prevent ICU-acquired weakness, and can be easily implemented in intensive care units.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiotherapy in Patients in a Cardiac Intensive Care Unit
NCT06402903
Exercise Rehabilitation in Patients With Severe Cardiopulmonary Dysfunction on Extracorporeal Life Support
NCT06792617
Effects os Physiotherapeutic Rehabilitation on Function Autonomic and Inflammatory in Patients With Long Covid
NCT07046208
Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.
NCT04244734
Exercise Prescriptions for Patients With Cardiovascular Disease
NCT05449652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active Physiotherapy Intervention Arm (n=75)
The subjects of one group will receive active physiotherapy (eg: verticalization, sitting on the edge of the bed, active breathing exercises).
Active Physiotherapy
Involves patient-driven exercises such as verticalization, sitting on the edge of the bed, and active breathing exercises.
Passive Physiotherapy Intervention Arm (n=75)
The other group will receive passive physiotherapy methods (eg: passive movements, electrostimulation of the diaphragm).
Passive Physiotherapy
Employs methods like passive movements and electrostimulation of the diaphragm, providing therapeutic benefits without requiring active patient engagement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Physiotherapy
Involves patient-driven exercises such as verticalization, sitting on the edge of the bed, and active breathing exercises.
Passive Physiotherapy
Employs methods like passive movements and electrostimulation of the diaphragm, providing therapeutic benefits without requiring active patient engagement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized in the Department of Reanimation and Intensive Therapy at LSMU Kaunas Clinics
* Diagnosis of respiratory failure (KFN) based on the following TLK-10-AM codes: J96.00, J96.01, J96.9, J96.10, J96.11, J96.19, J96.90, J96.91, J96.99
* Signed informed consent obtained from the patient or their legal representative
Exclusion Criteria
* Unconscious patients whose legal representative does not consent
* Recent episode of myocardial ischemia
* Pregnancy
* Heart rate \< 40 bpm or \> 130 bpm
* Mean arterial pressure \< 60 mmHg or \> 110 mmHg
* Oxygen saturation (SpO₂) ≤ 85%
* Body temperature ≥ 38.5°C or ≤ 36.0°C
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lithuanian University of Health Sciences
OTHER
Laura Rutkauskienė
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura Rutkauskienė
Clinical Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lithuanian University of Health Sciences
Kaunas, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol number 1 • Version 3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.